Editorji is a popular short video news and information platform based in India. It was founded in 2018 by Vikram Chandra, one of India’s leading journalists, and has risen to prominence in the digital news space in a relatively short span of time. The platform is primarily designed for mobile devices, with applications available for Android and iOS.

ABOUT US:

about us editorji

Latest Video News: Editorji provides the latest news video headlines, latest videos clip from India and the World. Get all breaking news videos on Entertainment, Business, Coronavirus, Elections, Politics and more.

Latest Video News, Breaking News, Bollywood, Political, Sports, Business News | Editorji

+91 11 4035 6666 / info@editorji.com
3rd floor, Plot B, Khasara no 360, Sultanpur, New Delhi, Delhi 110030
<a title="mail to us" href="mailto:info@editorji.com">Send Feedback</a>
<a title="Contact Us" href="mailto:info@editorji.com">Contact Us</a>

REACH US

Contact for any questions, suggestions, comments, feedback or advertisement on Editorji.com, we are always looking forward to hearing from you.

Contact Us for Feedback, Suggestions and Advertising 

Editorji content is better experienced in our app.

Italy on Friday recognised the Covishield Covid-19 vaccine. The number of European Union accepting the Covishield as valid proof of immunity of incoming travellers has moved to 19.
Indian vaccine cardholders are now eligible for the green pass, the Indian Embassy in Rome tweeted to inform.&nbsp; The tweet read that &lsquo;as an outcome of G20 health ministers&rsquo; meeting coupled with Indian foreign ministry persistent efforts, Italy has recognised India's Covishield&rsquo;
A green pass proves the holder has been fully vaccinated or recovered from Covid, granting them access to indoor restaurants, bars, cafes and other indoor venues.
Covishield, which is the AstraZeneca vaccine produced in India, is the most widely recognised vaccine for travel in the EU after those approved by European Medicines Agency (EMA).
Meanwhile, the United Kingdom is facing severe backlash over its latest international travel advisory. Even though the UK kept Covishield, manufactured by the SII, in its list of &lsquo;approved vaccines&rsquo;, it kept India in the list of countries whose travellers need to quarantine for 10 days when they reach the UK.

Italy recognises India's Covishield, jabbed travelers eligible for green pass

Italy recognised the Covishield Covid-19 vaccine. The number of European Union accepting the Covishield as valid proof of immunity of incoming travellers has moved to 19.

Italy recognised India's&nbsp;Covishield Covid-19 vaccine
19 EU nations have accepted Covishield&nbsp;as valid proof of immunity
Indian vaccine cardholders are 'now eligible for the green pass'
Covishield, EU's most widely recognised vaccine after those approved by EMA
UK facing backlash over its latest international travel advisory
UK:&nbsp;travellers from India need to quarantine for 10 days upon arrival
&nbsp;
&nbsp;

Covishield, which is the AstraZeneca vaccine produced in India, is the most widely recognised vaccine for travel in the EU after those approved by EMA.

Italy on Friday recognised the Covishield Covid-19 vaccine. The number of European Union countries accepting the Covishield as valid proof of immunity of incoming travellers has moved to 19.
Indian vaccine cardholders are now eligible for the green pass, the Indian Embassy in Rome tweeted to inform.&nbsp; The tweet read that &lsquo;as an outcome of G20 health ministers&rsquo; meeting coupled with Indian foreign ministry's persistent efforts, Italy has recognised India's Covishield&rsquo;
A green pass proves the holder has been fully vaccinated or recovered from Covid, granting them access to indoor restaurants, bars, cafes and other indoor venues.
Covishield, which is the AstraZeneca vaccine produced in India, is the most widely recognised vaccine for travel in the EU after those approved by European Medicines Agency (EMA).
Meanwhile, the United Kingdom is facing severe backlash over its latest international travel advisory. Even though the UK kept Covishield, manufactured by the SII, in its list of &lsquo;approved vaccines&rsquo;, it kept India in the list of countries whose travellers need to quarantine for 10 days when they reach the UK.

Adar Poonawalla backed Serum Insitute has applied for EU authorities nod for Covishield&nbsp;to ensure it is eligible for travellers to get the 'Green Pass' or vaccine passport for EU.&nbsp;&nbsp;The application has come at a time when beneficiaries of Covishield were termed ineligible for travelling to the European UnionReports indicate that Serum expects the vaccine to be cleared soon for emergency use authorisation with the EMA.&nbsp;COVID-19 vaccines developed by AstraZeneca, Pfizer, Moderna and Johnson and Johnson have received EMA's emergency use authorisation. Those administered these vaccines are eligible for the EU's digital certificate or Green Pass.&nbsp;

EU Green Pass: Serum applies for EU approval for Covishield

Adar Poonawalla wants to ensure that you can travel to Europe!&nbsp;

Poonawalla's push for green pass

<ul>
<li>Serum applies for EU drug regulator nod for Covishield&nbsp;</li>
<li>Covishield&nbsp;not eligibile for EU green pass without EMA&nbsp;nod</li>
<li>AstraZeneca&nbsp;manuactured&nbsp;vaccine has green pass nod, Covishield&nbsp;awaiting approval</li>
<li>Serum expects approval from EMA&nbsp;for&nbsp;Covishield&nbsp;soon</li>
<li>AstraZeneca, Pfizer, Moderna, J&amp;J jabs have nod from EU for Green Pass</li>
</ul>

Move follows reports that&nbsp;EU&rsquo;s vaccine passport recognizes Astra-Zeneca&rsquo;s Vaxzevria but not Covishield.&nbsp;

Adar Poonawalla backed Serum Insitute has applied for EU authorities nod for Covishield&nbsp;to ensure it is eligible for travellers to get the 'Green Pass' or vaccine passport for EU.&nbsp;&nbsp;The application has come at a time when beneficiaries of Covishield were termed ineligible for travelling to the European Union Reports indicate that Serum expects the vaccine to be cleared soon for emergency use authorisation with the EMA.&nbsp; COVID-19 vaccines developed by AstraZeneca, Pfizer, Moderna and Johnson and Johnson have received EMA's emergency use authorisation. Those administered these vaccines are eligible for the EU's digital certificate or Green Pass.&nbsp;

Serum's manufacturing site will have to assessed for Covishield to get Green Pass appoval by EMA&nbsp;as per reports.&nbsp;The EMA&nbsp;said that approval for&nbsp;AstraZenca&nbsp;manufatcured&nbsp;Vaxzevria&nbsp;does not mean nod for Covishiel. In an email as reported by News18 EMA&nbsp;stated&nbsp;&ldquo;Even tiny differences in the manufacturing conditions can result in differences in the final product, and EU law therefore requires the manufacturing sites and production process to be assessed and approved as part of the authorisation process.&rdquo;However, the EMA&nbsp;also has clarified that the authority to issue or approve a green pass for travellers rests with the EU nation members but is linked with linked to EU marketing authorisation for vaccines which currently Serum's Covishield&nbsp;does not have.&nbsp;

Green Pass nod for AstraZenca does not mean the same for Serum: EMA

Green Pass route not so easy,&nbsp;EMA to assess Serum's manufacturing site&nbsp;

Serum pushes for Green Pass for Covishield 

Serum's manufacturing site will have to assessed for Covishield to get Green Pass approval by EMA&nbsp;as per reports.&nbsp;
The EMA&nbsp;said that approval for&nbsp;AstraZenca&nbsp;manufatcured&nbsp;Vaxzevria&nbsp;does not mean nod for Covishiel. In an email as reported by News18 EMA&nbsp;stated&nbsp;&ldquo;Even tiny differences in the manufacturing conditions can result in differences in the final product, and EU law therefore requires the manufacturing sites and production process to be assessed and approved as part of the authorisation process.&rdquo;
However, the EMA&nbsp;also has clarified that the authority to issue or approve a green pass for travellers rests with the EU nation members but is linked with linked to EU marketing authorisation for vaccines which currently Serum's Covishield&nbsp;does not have.&nbsp;

EMA to assess Serum's manufacturing site before giving approval needed for Green Pass.

Serum's manufacturing site will have to assessed for Covishield to get Green Pass approval by EMA&nbsp;as per reports.&nbsp; The EMA&nbsp;said that approval for&nbsp;AstraZenca&nbsp;manufatcured&nbsp;Vaxzevria&nbsp;does not mean nod for Covishield. In an email as reported by News18 EMA&nbsp;stated&nbsp;&ldquo;Even tiny differences in the manufacturing conditions can result in differences in the final product, and EU law therefore requires the manufacturing sites and production process to be assessed and approved as part of the authorisation process.&rdquo; However, the EMA&nbsp;also has clarified that the authority to issue or approve a green pass for travellers rests with the EU nation members but is linked with linked to EU marketing authorisation for vaccines which currently Serum's Covishield&nbsp;does not have.&nbsp;

green pass

Categories